Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer

Launched by ADVANCED MARKER DISCOVERY S.L. · Mar 17, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on developing a new blood test that could help detect colorectal cancer and advanced adenomas (which are growths that can lead to cancer) at an early stage. Researchers want to combine information from blood samples, including specific markers, with details about patients' health and risk factors to create a more accurate way to identify those at risk for these conditions.

To participate in this study, you need to be at least 18 years old and able to understand the information provided and agree to take part. You should also be planning to have a colonoscopy or surgery for a tumor. However, if you’ve had any type of cancer in the last five years, received certain treatments like chemotherapy, or have specific health conditions, you may not be eligible. Participants will provide blood samples and health information, which will help researchers learn more about the effectiveness of this new test. It’s an exciting opportunity to contribute to advancements in early cancer detection!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients over the age of 18 who are able to understand the participant information and sign the informed consent.
• • Patients who are going to undergo colonoscopy or surgical resection for tumor (CRC).
• Exclusion Criteria:
• • Patients who had developed any type of cancer in the 5 years prior to their participation in this study.
• • Patients who have received previous chemotherapy or radiotherapy.
• • Patients diagnosed with non-advanced adenomas, serrated polyps, Familial Adenomatous Polyposis or Lynch Syndrome.
• • Patients with inadequate bowel preparation for colonoscopy.
• • Patients who have undergone colonoscopy/polipectomy in the previous 5 years.
• • Patients with hemolyzed plasma.